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We describe the implementation of a fluence convolution method to account for the influence of
superior-inferior ~SI! respiratory induced motion on a Monte Carlo-based dose calculation of a
tumor located in the liver. This method involves convolving the static fluence map with a function
describing the SI motion of the liver—the motion function has been previously derived from
measurements of diaphragm movement observed under fluoroscopy. Significant differences are
noted between fluence-convolved and static dose distributions in an example clinical treatment
plan; hot and cold spots ~on the order of 25%! are observed in the fluence-convolved plan at the
superior and inferior borders of the liver, respectively. This study illustrates that the fluence con-
volution method can be incorporated into Monte Carlo dose calculation algorithms to account for
some of the effects of patient breathing during radiotherapy treatment planning, thus leading to
more accurate dose calculations. © 2003 American Association of Physicists in Medicine.
@DOI: 10.1118/1.1581412#The standard computation of dose distributions in conformal
radiotherapy is based on a single instance of patient anatomy.
However, as a consequence of patient breathing and the as-
sociated changes in organ anatomy, differences will result
between the planned dose distribution and that actually de-
livered. Therefore, the incorporation of uncertainties due to
organ motion resulting from respiration is a very important
requirement for accurate dose calculation within a given
treatment plan.1–5 One particular method to account for
respiratory-induced organ motion is to convolve the static
dose distributions with functions that approximate the
breathing.4,5 A study by Lujan et al.4 has shown that apply-
ing a single convolution to the static dose distribution, for
patients undergoing irradiation of the liver, is sufficient to
predict the dose distribution for the given treatment plan;
intrafraction effects were found to average out over the
course of many fractions. A potential limitation of the dose
convolution approach is that it is based on the assumption
that the dose distribution is spatially invariant, i.e., the con-
volution of dose is conducted in an assumed homogeneous
medium without cognizance of the variation in patient tissue
densities. In a recent study, Beckham et al.,6 have applied a
fluence-convolution method to incorporate random setup er-
ror in the dose calculation. Specifically, Beckham et al.6 use
the Monte Carlo method to sample the photon fluence that is
first convolved with a 2D Gaussian random setup error ker-
nel. Beckham et al.6 point out that fluence convolution is
more accurate than dose convolution in heterogeneous media
since fluence convolution correctly models the spatial varia-
tion of dose resulting from movement due to setup error. In
this study, we extend the concept of fluence convolution to
account for respiratory motion in a clinically realistic treat-
ment plan for a lesion located within the liver. We compare
calculations using the fluence convolution method with those
from the static ~no motion! case, as well as with a treatment
plan generated using the dose convolution method.1776 Med. Phys. 30 7, July 2003 0094-2405Õ2003Õ307The treatment planning study has been conducted using
the UMPlan ~University of Michigan, Ann Arbor, MI! treat-
ment planning software. Dose calculations for both fluence
and dose-based convolution have been performed using the
DI ose PI lanning MI ethod ~DPM! Monte Carlo code system,7,8
which has been integrated within UMPlan. The Monte Carlo
virtual source model used for patient-specific dose calcula-
tions is similar to that developed by Chetty et al.,9 and is
described at length in that paper. However, a brief descrip-
tion of the source model is necessary here. The treatment
head components of a Varian 21EX linear accelerator ~Varian
Associates, Palo Alto, CA! were simulated using the BEAM-
nrc Monte Carlo code ~CNRC, Ottawa, CN!. A virtual source
model was reconstructed from the phase space distribution to
sample the source particle’s position, energy, and direction.
Arbitrary field shapes are simulated by multiplying the un-
collimated fluence map by a matrix describing the multileaf
collimator ~MLC! configuration—the composite fluence ma-
trix includes a correction for leaf edge penumbral effects.9
The fluence convolution method to correct for respiratory-
induced motion of the liver was implemented by convolving
the static fluence distribution, Fstatic , with a probability dis-
tribution function associated with breathing induced dia-
phragmatic displacement, labeled Fmotion in this paper, to
generate a composite fluence map, Fmotion , which is used to
sample the source particle’s position. Fstatic represents the
MLC-shaped field static fluence distribution and is located in
a plane perpendicular to the beam central axis, between the
accelerator and the patient. For a point, r , that includes the
motion, we then have
Fmotion~r !5Fmotion^ Fstatic
5E
r8
Fmotion~r2r8!Fstatic~r8!dr8. ~1!1776Õ1776Õ5Õ$20.00 © 2003 Am. Assoc. Phys. Med.
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map ~fluence convolved dose—static
dose! in the sagittal view. Both treat-
ment plans have been normalized to
100% at the isocenter. Included are the
isodose lines corresponding to the
620% differences ~solid yellow lines!
and the 610% differences ~dashed
yellow lines!. Nonhighlighted differ-
ences ~dark regions! are within 62%.Fmotion has been developed by Lujan et al.,4 based on the
correlation between the liver and the diaphragm movements
~as observed under fluoroscopy by Balter et al.10! and is
given by
Fmotion~z !5H napS z02za D (2n21)/2n
3F12S z02z
a
D 1/nG1/2J 21
for z02a,z,z0 , ~2!
where z0 is the position at exhale, a the amplitude of motion
~patient specific, 1.5 cm in our study!, and n53, a parameter
that describes the general shape of the model. In the Monte
Carlo implementation, Fmotion is divided into 15 equally
spaced probability bins, from the position at exhale (z0) to
the position at inhale (z02a). The position (x , y at a fixed z
location! and energy for each particle starting from the vir-
tual source is determined by first sampling Fstatic . The
source particle’s incident direction is determined from the
position coordinates assuming that the particle originated
from a point,9 i.e., u5x/R , v5y /R , w5z/R , where R
5Ax21y21z2. To account for the motion in the SI direc-
tion, Fmotion is sampled to determine the positional transla-
tion, dz; the particle’s z coordinate is then translated accord-
ing to the relation: z85z1dz . Note that the particle’s x and
y coordinates remain unchanged as Fmotion incorporates mo-
tion in only the z ~SI! dimension. The following relation may
then be used to describe the coordinate transformation from
the static fluence distribution Fstatic , in the unprimed coor-
dinates, to the motion convolved fluence, Fmotion , in the
primed coordinates:
x85x , y85y , and z85z1dz . ~3!Medical Physics, Vol. 30, No. 7, July 2003The direction cosine vectors for each source particle are also
appropriately modified as there is a change in R from the
translation of z ,
u5
x8
R , v5
y8
R , and w5
z8
R ,
where R5A~x821y821z82!. ~4!
The fluence convolution method described here is different
from that of Beckham et al.,6 where the x , y position coor-
dinates of each source particle in the phase space file are
resampled according to a 2D Gaussian random setup error
kernel. In addition to differences in the positional sampling
and in the treatment head description ~phase space versus
virtual source model!, Beckham et al.6 do not recalculate the
direction vectors for each translated source particle, as we do
in our implementation.
The influence of respiratory motion on the dose distribu-
tion was also evaluated using a dose convolution method,4
performed by convolving the static dose distribution, Dstatic
~calculated using Fstatic) with the function, Fmotion , de-
scribed above. The dose at a point r , that includes the mo-
tion, is calculated as follows:
Dmotion~r !5Fmotion^ Dstatic
5E
r8
Fmotion~r2r8!Dstatic~r8!dr8, ~5!
Fmotion is cast in the form of a 1D discrete matrix along the z
~SI! dimension of the patient, and is convolved with Dstatic so
that the integral shown in Eq. ~1! is reduced to a summation.
The treatment plan beam configuration consisted of 15
MV anterior, lateral and oblique fields, combined with seg-
mental fields ~directed from the same angles! to produce a
dose distribution of 10065% within the planning target vol-
1778 Chetty et al.: Monte Carlo fluence convolution respiratory motion liver 1778FIG. 2. Isodose lines: 95%, 50%, and
20%, calculated using the fluence con-
volution ~solid blue lines! and dose
convolution ~dashed yellow lines!
methods, in the coronal view. Both
treatment plans have been normalized
to 100% at the isocenter.ume ~PTV!. The CT data set used for treatment planning was
acquired at exhale, under voluntary breath hold. The treat-
ment planning volumes: gross tumor volume ~GTV!, clinical
target volume ~CTV!, and planning target volume ~PTV! are
those defined by the ICRU Report No. 50,11 and are derived
in this work from our current liver treatment protocol.12 The
CTV is formed by a uniform, 1 cm expansion of the GTV.Medical Physics, Vol. 30, No. 7, July 2003The PTV includes a uniform 0.5 cm margin for setup uncer-
tainties, as well as a 0.3 cm margin superiorly ~added to
account for the reproducibility of the exhale CT scan! and a
1.5 cm margin inferiorly to account for patient breathing—
these expansions are performed relative to the CTV.4
DPM calculations were conducted using a voxel size of
33331 mm3 ~in the x , y , z dimensions!, a 2 mm step size,FIG. 3. Dose volume histograms for the CTV shown for the static ~solid black line!, fluence convolved ~dashed blue line! and dose convolved ~solid orange
line! treatment plans. The inset represents a magnification of the high gradient region of the DVH, between the 95% and 105% dose values.
1779 Chetty et al.: Monte Carlo fluence convolution respiratory motion liver 1779FIG. 4. Dose volume histograms for
the CT-scanned right lung volume
shown for the static ~solid black line!,
fluence convolved ~dashed blue line!
and dose convolved ~solid orange line!
treatment plans.and low energy electron and photon cutoff values of 200 and
50 keV, respectively. For each treatment plan, 6 billion his-
tories were simulated ~1 billion histories per field!, resulting
in 1s statistics of roughly less than 1.5% in calculated dose,
if we combine the inherent uncertainty in the reconstructed
fluence ~from the virtual source! of 1%. The time required
for these simulations was approximately 10 hours per 1 bil-
lion particles, running on a single 1 GHz, VMS-based, Alpha
processor.
Figure 1 illustrates a percentage difference map ~in the
sagittal view! between fluence convolved and static dose dis-
tributions. The difference map was calculated by subtracting
the static dose from the fluence convolved dose for each
point in the dose distribution. The fluence convolved and
static treatment plans were normalized to 100% at the iso-
center ~located within the PTV!, as is routinely done for
patients planned on our liver treatment protocol.4,12 The dif-
ference between the absolute doses in the static and dose
convolved plans at the isocenter, located within the central
homogeneous region of the PTV, is negligible. The red color
wash regions in Fig. 1 represent areas of positive dose dif-
ferences indicating that the dose in the fluence convolved
plan is higher than that in the static plan. Similarly, the blue
color wash corresponds to regions where the fluence con-
volved doses are lower than those in the static treatment
plan. Also, presented in Fig. 1 are the isodose regions corre-
sponding to differences of 620% ~in the solid lines! and
610% ~in the dashed lines!. Maximum point differences of
125% are observed in the region superior to the PTV, lo-
cated within the lung. The differences observed in Fig. 1 are
a consequence of the motion of the liver due to breathing.
Given that the CT scan was acquired at the exhale position, it
is expected that, during inhale, the expansion of the lung will
force the liver to move inferiorly. This means that the regionMedical Physics, Vol. 30, No. 7, July 2003of lung tissue located superiorly to the PTV will be exposed
to radiation, while the inferior portion of the PTV will be
blocked and will tend to be under-dosed, as noted in Fig. 1.
Presented in Fig. 2 are the 95%, 50%, and 20% isodose lines
for the treatment plans generated using the fluence convolu-
tion ~solid blue lines! and the dose convolution ~dashed yel-
low lines! methods, in the coronal view. The differences be-
tween these two plans are within 62% on average, however,
the differences might well be larger had the PTV not ex-
tended outside the liver into the lung; the influence of the
PTV, protruding into the lung, tends to minimize differences
between the spatially invariant dose distribution ~an assump-
tion required for dose convolution! and the spatially variant
dose distribution ~as calculated with fluence convolution!.
The reason for this is that the Monte Carlo static dose calcu-
lation is expected to correctly account for the spread of dose
into the lung ~at the superior edge of the PTV!; convolving
the static dose in this region is therefore likely to be as ac-
curate as the fluence convolved calculation. It is clear, how-
ever, that a much more extensive investigation ~involving
many treatment plans! is necessary before conclusions can be
drawn regarding the dosimetric differences between the flu-
ence and dose convolution approaches used in accounting for
breathing-induced organ motion in the vicinity of the liver.
Analyses of dose volume histograms ~DVHs! for the CTV
and the right lung were conducted for the static, fluence and
dose convolved treatment plans. For the CTV, DVH differ-
ences between the static and the motion convolved ~fluence
or dose convolved! dose distributions are relatively small ~as
noted in Fig. 3! indicating that the margin between CTV and
PTV adequately accounts for the motion. However, in this
particular example, differences in the PTV DVHs between
the static and motion convolved doses were also found to be
negligible. A likely reason for this is that only the very su-
1780 Chetty et al.: Monte Carlo fluence convolution respiratory motion liver 1780perior and inferior regions of the PTV are influenced by the
motion, so that the resulting influence on the DVH is small.
Figure 4 illustrates DVHs for the scanned right lung volume
generated from the static and motion convolved treatment
plans. Significant differences are noted for the motion-
convolved plans in comparison to the static treatment plan.
For example, the volume of lung receiving doses greater than
50% of the isocenter dose is 17% higher in the fluence con-
volved treatment plan relative to the static case. Such differ-
ences may be clinically relevant.
In this study, we have implemented a fluence convolution
method to account for the influence of liver motion ~in the
superior-inferior direction! due to breathing on the 3D dose
distribution. We have tested this method on a clinical treat-
ment plan and have found significant differences between the
fluence convolved and static dose distributions, indicating
the importance of organ motion in treatment planning. Al-
though the fluence convolution method assumes a rigid-body
approximation and ignores intrafraction effects much like the
dose convolution approach, it can be incorporated to provide
a more accurate dose distribution. The focus of future work
will be to conduct an extensive treatment planning study of
the fluence convolution method, involving lesions located at
various locations within the liver as well as in other anatomi-
cal regions, such as the lung.
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